Parental perceived benefits of OROS-methylphenidate treatment for the child with attention-deficit/hyperactivity disorder and for parents themselves

• Published in: Pharmacopsychiatry Vol. 46; no. 4; p. 137
• Main Authors: Kim, J-W, Park, S, Kim, B-N, Shin, M-S, Cho, S-C, Kim, J-H, Son, J-W, Shin, Y-M, Chung, U-S, Han, D-H
• Format: Journal Article
• Language: English
• Published: Germany 01.06.2013
• Subjects: Adult; Asian Continental Ancestry Group; Attention - physiology; Attention Deficit Disorder with Hyperactivity - drug therapy; Attention Deficit Disorder with Hyperactivity - psychology; Caregivers - psychology; Central Nervous System Stimulants - administration & dosage; Central Nervous System Stimulants - adverse effects; Central Nervous System Stimulants - therapeutic use; Child; Depression - psychology; Diagnostic and Statistical Manual of Mental Disorders; Educational Status; Female; Humans; Male; Methylphenidate - administration & dosage; Methylphenidate - adverse effects; Methylphenidate - therapeutic use; Middle Aged; Neuropsychological Tests; Parenting - psychology; Parents - psychology; Republic of Korea; Stress, Psychological - psychology; Treatment Outcome; Republic of Korea
• ISSN: 1439-0795
• DOI: 10.1055/s-0032-1331749

Given the shortage of studies on parental perceived benefits of OROS-methylphenidate treatment in Asian populations, we assessed parental response to OROS-methylphenidate treatment of Korean children with attention-deficit/hyperactivity disorder (ADHD), in relation to children's academic performance and behavioral symptoms as well as parental rearing stress and depressive symptoms.We enrolled 132 medication-naïve children with ADHD into a multicenter, open-label, 12-week trial of OROS-MPH. The outcome measures were the ADHD rating scale-IV (ADHD-RS), the comprehensive attention test and academic performance rating scale, and the clinical global impression (CGI)-severity/improvement instrument (for the children) and Beck depression inventory and parenting stress index (for their parents).We found parent-perceived improvements in children's ADHD-related behavioral symptoms and academic function and their parents' depressive symptoms and parenting stress. Investigator-rated ADHD symptoms and subjects' neuropsychological function were also improved (p<0.001).Parents of Korean children with ADHD perceive that OROS-methylphenidate treatment improves their children's academic function and behavior as well as their own child-rearing stress and emotional state. These findings must be interpreted with caution, due to a non-comparative open-label trial.